Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Article in English | MEDLINE | ID: mdl-27462149

ABSTRACT

INTRODUCTION: Severe chronic obstructive pulmonary disease (COPD) is often associated with secondary pulmonary hypertension (PH), which worsens prognosis. PH can be lowered by oxygen, but also by inhaled nitric oxide (NO), which has the potential to improve the health status of these patients. NO is an important mediator in vascular reactions in the pulmonary circulation. Oral compounds can act through NO-mediated pathways, but delivering pulsed inhaled NO (iNO) directly to the airways and pulmonary vasculature could equally benefit patients. Therefore, a proof-of-concept study was performed to quantify pulmonary blood vessel caliber changes after iNO administration using computed tomography (CT)-based functional respiratory imaging (FRI). METHODS: Six patients with secondary PH due to COPD received "pulsed" iNO in combination with oxygen for 20 minutes via a nasal cannula. Patients underwent a high-resolution CT scan with contrast before and after iNO. Using FRI, changes in volumes of blood vessels and associated lobes were quantified. Oxygen saturation and blood pressure were monitored and patients were asked about their subjective feelings. RESULTS: Pulmonary blood vessel volume increased by 7.06%±5.37% after iNO. A strong correlation (Ω(2) 0=0.32, P=0.002) was obtained between ventilation and observed vasodilation, suggesting that using the pulsed system, iNO is directed toward the ventilated zones, which consequently experience more vasodilation. Patients did not develop oxygen desaturation, remained normotensive, and perceived an improvement in their dyspnea sensation. CONCLUSION: Inhalation of pulsed NO with oxygen causes vasodilation in the pulmonary circulation of COPD patients, mainly in the well-ventilated areas. A high degree of heterogeneity was found in the level of vasodilation. Patients tend to feel better after the treatment. Chronic use trials are warranted.


Subject(s)
Antihypertensive Agents/administration & dosage , Hypertension, Pulmonary/drug therapy , Lung/blood supply , Nitric Oxide/administration & dosage , Oxygen Inhalation Therapy , Pulmonary Artery/drug effects , Pulmonary Disease, Chronic Obstructive/therapy , Vasodilation/drug effects , Vasodilator Agents/administration & dosage , Administration, Inhalation , Aged , Antihypertensive Agents/adverse effects , Arterial Pressure/drug effects , Computed Tomography Angiography , Female , Forced Expiratory Volume , Humans , Hypertension, Pulmonary/diagnosis , Hypertension, Pulmonary/etiology , Hypertension, Pulmonary/physiopathology , Lung/physiopathology , Male , Nitric Oxide/adverse effects , Oxygen Inhalation Therapy/adverse effects , Patient Satisfaction , Perfusion Imaging , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/physiopathology , Pulmonary Circulation/drug effects , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/physiopathology , Pulse Therapy, Drug , Time Factors , Treatment Outcome , Vasodilator Agents/adverse effects , Vital Capacity
2.
Article in English | MEDLINE | ID: mdl-26917956

ABSTRACT

BACKGROUND: Patients with COPD show a significant reduction of the lobar hyperinflation at the functional residual capacity level in the patients who improved >120 mL in forced expiratory volume in 1 second (FEV1) after 6 months of treatment with roflumilast in addition to inhaled corticosteroids (ICSs)/long-acting beta-2 agonists (LABAs)/long-acting muscarinic antagonists (LAMAs). METHODS: Functional respiratory imaging was used to quantify lobar hyperinflation, blood vessel density, ventilation, aerosol deposition, and bronchodilation. To investigate the exact mode of action of roflumilast, correlations between lobar and global measures have been tested using a mixed-model approach with nested random factors and Pearson correlation, respectively. RESULTS: The reduction in lobar hyperinflation appears to be associated with a larger blood vessel density in the respective lobes (t=-2.154, P=0.040); lobes with a higher percentage of blood vessels reduce more in hyperinflation in the responder group. Subsequently, it can be observed that lobes that reduce in hyperinflation after treatment are better ventilated (t=-5.368, P<0.001). Functional respiratory imaging (FRI)-based aerosol deposition showed that enhanced ventilation leads to more peripheral particle deposition of ICS/LABA/LAMA in the better-ventilated areas (t=2.407, P=0.024). Finally, the study showed that areas receiving more particles have increased FRI-based bronchodilation (t=2.564, P=0.017), leading to an increase in FEV1 (R=0.348, P=0.029). CONCLUSION: The study demonstrated that orally administered roflumilast supports the reduction of regional hyperinflation in areas previously undertreated by inhalation medication. The local reduction in hyperinflation induces a redistribution of ventilation and aerosol deposition, leading to enhanced efficacy of the concomitant ICS/LABA/LAMA therapy. FRI appears to be a sensitive tool to describe the mode of action of novel compounds in chronic obstructive pulmonary disease. Future studies need to confirm the enhanced sensitivity and the potential of FRI parameters to act as surrogates for clinically relevant, but more difficult to measure, end points such as exacerbations.


Subject(s)
Adrenal Cortex Hormones/administration & dosage , Aminopyridines , Benzamides , Muscarinic Antagonists/administration & dosage , Pulmonary Disease, Chronic Obstructive , Pulmonary Ventilation/drug effects , Respiratory Function Tests/methods , Administration, Inhalation , Administration, Oral , Adrenergic beta-2 Receptor Agonists/administration & dosage , Aged , Aminopyridines/administration & dosage , Aminopyridines/pharmacokinetics , Benzamides/administration & dosage , Benzamides/pharmacokinetics , Bronchodilator Agents/administration & dosage , Cyclopropanes/administration & dosage , Cyclopropanes/pharmacokinetics , Drug Therapy, Combination/methods , Female , Humans , Male , Middle Aged , Phosphodiesterase 4 Inhibitors/administration & dosage , Phosphodiesterase 4 Inhibitors/pharmacokinetics , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/drug therapy , Pulmonary Disease, Chronic Obstructive/physiopathology , Severity of Illness Index , Tissue Distribution , Tomography, X-Ray Computed/methods , Treatment Outcome
3.
J Aerosol Med Pulm Drug Deliv ; 28(2): 88-99, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25004168

ABSTRACT

BACKGROUND: The efficacy of inhaled corticosteroids (ICS) in moderately severe COPD patients remains unclear. At the same time, the use of extrafine particles in COPD patients is a topic of ongoing research. OBJECTIVES: This study assessed the effect of ICS in steroid-naïve mild COPD patients and the effect of reducing the ICS dose in more severe COPD patients previously using ICS when switching to an extrafine particle BDP/F formulation (Foster using Modulite technology, Chiesi Pharmaceutici, Parma, Italy). METHODS: Novel functional respiratory imaging (FRI) methods, consisting of multi-slice CT scans and Computational Fluid Dynamics, were used in combination with conventional pulmonary function tests and patient reported outcomes. RESULTS: The study showed that the administration of extrafine BDP/F after 4-6 h led to a significant improvement in lung function parameters and hyperinflation as determined by spirometry, body plethysmography, and functional respiratory imaging. After 6 months of treatment, it was observed that, compared to baseline, the hyperinflation on lobar level at total lung capacity was significantly reduced (-1.19±7.19 %p, p=0.009). In addition, a significant improvement in SGRQ symptom score was noted in the entire patient population. Patients who improved in terms of hyperinflation also improved their MMRC dyspnea score. CFD indicated a difference in regional deposition between extrafine and non-extrafine formulations with -11% extrathoracic deposition and up to +4% lobe deposition for the extrafine formulation. CONCLUSIONS: The study showed that the administration of extrafine BDP/F improved lung function parameters and hyperinflation. Patients previously treated with ICS remained stable despite the lower dose, while ICS naïve patients improved in terms of lobar hyperinflation. FRI seems to be a sensitive biomarker to detect clinically relevant changes that are not detected by spirometry. The next step is to confirm these findings in a controlled trial.


Subject(s)
Adrenergic beta-2 Receptor Agonists/administration & dosage , Beclomethasone/administration & dosage , Bronchodilator Agents/administration & dosage , Dyspnea/drug therapy , Formoterol Fumarate/administration & dosage , Glucocorticoids/administration & dosage , Lung/drug effects , Multidetector Computed Tomography , Pulmonary Disease, Chronic Obstructive/drug therapy , Administration, Inhalation , Adrenergic beta-2 Receptor Agonists/chemistry , Aerosols , Aged , Aged, 80 and over , Beclomethasone/chemistry , Bronchodilator Agents/chemistry , Chemistry, Pharmaceutical , Dyspnea/diagnosis , Dyspnea/physiopathology , Female , Forced Expiratory Volume , Formoterol Fumarate/chemistry , Glucocorticoids/chemistry , Humans , Lung/diagnostic imaging , Lung/physiopathology , Male , Middle Aged , Particle Size , Pilot Projects , Plethysmography, Whole Body , Powders , Predictive Value of Tests , Prospective Studies , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/physiopathology , Radiographic Image Interpretation, Computer-Assisted , Recovery of Function , Severity of Illness Index , Spirometry , Time Factors , Treatment Outcome , Vital Capacity
5.
Article in English | MEDLINE | ID: mdl-24293993

ABSTRACT

BACKGROUND: Previous studies have demonstrated the potential beneficial effect of N-acetylcysteine (NAC) in chronic obstructive pulmonary disease (COPD). However, the required dose and responder phenotype remain unclear. The current study investigated the effect of high-dose NAC on airway geometry, inflammation, and oxidative stress in COPD patients. Novel functional respiratory imaging methods combining multislice computed tomography images and computer-based flow simulations were used with high sensitivity for detecting changes induced by the therapy. METHODS: Twelve patients with Global Initiative for Chronic Obstructive Lung Disease stage II COPD were randomized to receive NAC 1800 mg or placebo daily for 3 months and were then crossed over to the alternative treatment for a further 3 months. RESULTS: Significant correlations were found between image-based resistance values and glutathione levels after treatment with NAC (P = 0.011) and glutathione peroxidase at baseline (P = 0.036). Image-based resistance values appeared to be a good predictor for glutathione peroxidase levels after NAC (P = 0.02), changes in glutathione peroxidase levels (P = 0.035), and reduction in lobar functional residual capacity levels (P = 0.00084). In the limited set of responders to NAC therapy, the changes in airway resistance were in the same order as changes induced by budesonide/formoterol. CONCLUSION: A combination of glutathione, glutathione peroxidase, and imaging parameters could potentially be used to phenotype COPD patients who would benefit from addition of NAC to their current therapy. The findings of this small pilot study need to be confirmed in a larger pivotal trial.


Subject(s)
Acetylcysteine/therapeutic use , Airway Resistance/drug effects , Antioxidants/therapeutic use , Lung/drug effects , Oxidative Stress/drug effects , Pulmonary Disease, Chronic Obstructive/drug therapy , Aged , Computer Simulation , Cross-Over Studies , Female , Forced Expiratory Volume , Functional Residual Capacity , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Humans , Lung/immunology , Lung/metabolism , Lung/physiopathology , Male , Middle Aged , Models, Biological , Multidetector Computed Tomography , Phenotype , Pilot Projects , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/immunology , Pulmonary Disease, Chronic Obstructive/metabolism , Pulmonary Disease, Chronic Obstructive/physiopathology , Time Factors , Treatment Outcome
6.
Article in English | MEDLINE | ID: mdl-23055715

ABSTRACT

OBJECTIVE: Chest physiotherapy enhances sputum evacuation in COPD patients. It can be applied as a single technique or as a combination of techniques including intrapulmonary percussive ventilation (IPV). Recently developed assessment techniques may provide new insights into the effect of airway clearance techniques. PARTICIPANTS: Five moderate to severe COPD patients (three females and two males; mean forced expiratory volume in 1 second of 39.49% predicted) who were admitted in the hospital for an acute exacerbation were included in this study. METHODS: A novel imaging technique was used, together with other conventional techniques, to visualize the short-term effects of a single IPV treatment in COPD patients. RESULTS: No significant changes were noted in the lung function parameters or arterial blood gases measured within 1 hour after the end of the IPV session. Computed tomography images detected changes in the airway patency after the IPV treatment compared with before treatment. Local resistances, calculated for the three-dimensional models, showed local changes in airway resistance. CONCLUSION: The effects of a single IPV session can be visualized by functional imaging. This functional imaging allows a calculation of changes in local airway resistance and local changes in airway volume in COPD patients without affecting conventional lung function parameters.


Subject(s)
Computer Simulation , Lung/diagnostic imaging , Models, Biological , Pulmonary Disease, Chronic Obstructive/diagnostic imaging , Pulmonary Disease, Chronic Obstructive/therapy , Radiographic Image Interpretation, Computer-Assisted/methods , Respiration, Artificial/methods , Respiratory Therapy/methods , Tomography, X-Ray Computed , Airway Resistance , Belgium , Blood Gas Analysis , Female , Forced Expiratory Volume , Hospitalization , Humans , Hydrodynamics , Imaging, Three-Dimensional , Lung/physiopathology , Lung Volume Measurements , Male , Predictive Value of Tests , Pulmonary Disease, Chronic Obstructive/physiopathology , Severity of Illness Index , Time Factors , Treatment Outcome
7.
Eur J Ageing ; 8(4): 233-241, 2011 Dec.
Article in English | MEDLINE | ID: mdl-28798653

ABSTRACT

Developed countries throughout the world are challenged with the ageing of their labour force. In these societal contexts, low employment rates and early labour market exits of older employees are at stake, as well as arrangements for retirement, financial household considerations and mutual obligations between generations. Although proactive behaviour has been extensively studied, no research has addressed the proactive behaviour of older employees themselves when facing (re)hiring and retention versus early retirement. For the first time, this study tests the relationships of proactive behaviour with job-related affective well-being and anticipated retirement age in a sample of employees aged 50+ (N = 89) in Belgium. The findings are obtained by using a self-report questionnaire. Statistical analysis includes correlation and regression analysis. Major findings are that (i) proactive older employees feel energetic, enthusiastic, inspired, at ease, relaxed and satisfied; and (ii) later retirement is anticipated when experiencing positive affective well-being at study.

8.
Radiology ; 257(3): 854-62, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21084417

ABSTRACT

PURPOSE: To compare the results obtained by using numerical flow simulations with the results of combined single photon emission computed tomography (SPECT) and computed tomography (CT) and to demonstrate the importance of correct boundary conditions for the numerical methods to account for the large amount of interpatient variability in airway geometry. MATERIALS AND METHODS: This study was approved by all relevant institutional review boards. All patients gave their signed informed consent. In this study, six patients with mild asthma (three men; three women; overall mean age, 46 years ± 17 [standard deviation]) underwent CT at functional residual capacity and total lung capacity, as well as SPECT/CT. CT data were used for segmentation and computational fluid dynamics (CFD) simulations. A comparison was made between airflow distribution, as derived with (a) SPECT/CT through tracer concentration analysis, (b) CT through lobar expansion measurement, and (c) CFD through flow computer simulation. Also, the heterogeneity of the ventilation was examined. RESULTS: Good agreement was found between SPECT/CT, CT, and CFD in terms of airflow distribution and hot spot detection. The average difference for the internal airflow distribution was less than 3% for CFD and CT versus SPECT/CT. Heterogeneity in ventilation patterns could be detected with SPECT/CT and CFD. CONCLUSION: This results of this study show that patient-specific computer simulations with appropriate boundary conditions yield information that is similar to that obtained with functional imaging tools, such as SPECT/CT. SUPPLEMENTAL MATERIAL: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.10100322/-/DC1.


Subject(s)
Asthma/diagnostic imaging , Tomography, Emission-Computed, Single-Photon , Tomography, X-Ray Computed , Adult , Aerosols/administration & dosage , Aged , Asthma/physiopathology , Female , Humans , Male , Middle Aged , Models, Anatomic , Radiographic Image Interpretation, Computer-Assisted , Radiopharmaceuticals/administration & dosage , Respiratory Function Tests , Software , Technetium Tc 99m Pentetate/administration & dosage
9.
Chest ; 134(6): 1169-1175, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18689597

ABSTRACT

BACKGROUND: To investigate the relationship between obstructive sleep apnea syndrome (OSAS) and exhaled nitric oxide (eNO) in overweight children and adolescents without asthma or atopy and to assess whether obesity per se is associated with increased airway inflammation. METHODS: Consecutive overweight subjects without symptoms of asthma or allergy were recruited at a pediatric obesity clinic. A normal-weight control group without OSAS and asthma or allergy was also recruited. All subjects underwent polysomnography and two measurements of eNO (afternoon and morning after polysomnography). RESULTS: Controlling for age, the mean (+/- SD) afternoon eNO concentration was significantly higher in the snoring group (14.1 +/- 1.1 parts per billion [ppb]) compared with the normal-weight group (10.1 +/- 0.8 ppb; p = 0.03) and with the overweight group with normal polysomnography findings (8.9 +/- 0.8 ppb; p = 0.007). The afternoon eNO concentration was also different between the OSAS group (11.9 +/- 1.0 ppb) and the overweight group with normal polysomnography findings (p = 0.03). Morning eNO values were higher in the OSAS group (12.3 +/- 1.1 ppb) than in the normal weight group (9.9 +/- 0.8 ppb; p = 0.047) and in the overweight control group (9.7 +/- 0.7 ppb; p = 0.02). BMI z score was not significantly correlated with afternoon eNO concentration or with morning eNO concentration. CONCLUSION: This study illustrates that both habitual snoring and OSAS are associated with increased airway inflammation in overweight children as assessed by higher eNO levels. Furthermore, it was demonstrated that childhood obesity in the absence of sleep-disordered breathing is not associated with increased airway inflammation.


Subject(s)
Asthma/epidemiology , Obesity/complications , Sleep Apnea, Obstructive/epidemiology , Adolescent , Asthma/metabolism , Asthma/physiopathology , Body Mass Index , Breath Tests , Case-Control Studies , Child , Cohort Studies , Female , Humans , Male , Nitric Oxide/metabolism , Obesity/metabolism , Obesity/physiopathology , Polysomnography , Pulmonary Ventilation/physiology , Risk Factors , Sleep Apnea, Obstructive/metabolism , Sleep Apnea, Obstructive/physiopathology , Snoring/epidemiology , Snoring/metabolism , Snoring/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...